These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

112 related articles for article (PubMed ID: 16563055)

  • 21. Efficacy and safety of novel antipsychotics: a critical review.
    Balestrieri M; Vampini C; Bellantuono C
    Hum Psychopharmacol; 2000 Oct; 15(7):499-512. PubMed ID: 12404619
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The International Psychogeriatric Association--ninth congress. 15-20 August 1999, Vancouver, Canada.
    Draper B
    IDrugs; 1999 Nov; 2(11):1133-5. PubMed ID: 16113983
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Light therapy for behavioural and psychological symptoms of dementia.
    Skjerve A; Bjorvatn B; Holsten F
    Int J Geriatr Psychiatry; 2004 Jun; 19(6):516-22. PubMed ID: 15211528
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Indications of atypical antipsychotics in the elderly.
    McKean A; Monasterio E
    Expert Rev Clin Pharmacol; 2015 Jan; 8(1):5-7. PubMed ID: 25354148
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Use of antipsychotics in elderly patients with dementia: do atypical and conventional agents have a similar safety profile?
    Trifirò G; Spina E; Gambassi G
    Pharmacol Res; 2009 Jan; 59(1):1-12. PubMed ID: 18977443
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A Narrative Review of Studies Comparing Efficacy and Safety of Citalopram with Atypical Antipsychotics for Agitation in Behavioral and Psychological Symptoms of Dementia (BPSD).
    Qasim HS; Simpson MD
    Pharmacy (Basel); 2022 Jun; 10(3):. PubMed ID: 35736776
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Drug treatment for oral submucous fibrosis.
    Angadi PV
    Evid Based Dent; 2010; 11(2):56. PubMed ID: 20577289
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Antipsychotic use in elderly patients and the risk of pneumonia.
    Gambassi G; Sultana J; Trifirò G
    Expert Opin Drug Saf; 2015 Jan; 14(1):1-6. PubMed ID: 25431005
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment of psychosis in Parkinson's disease.
    D'Souza S; Barnett SK; Rangu S; Rowland FN
    J Am Med Dir Assoc; 2000; 1(5):211-6. PubMed ID: 12812621
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [State of the art management of BPSD in dementia].
    Rainer MK; Mucke HA; Masching AJ; Haushofer M; Karger M; Kasper S; Kurz A
    Psychiatr Prax; 2005 Jan; 32(1):31-8. PubMed ID: 15633073
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Behavioral and Psychological Symptoms in Dementia (BPSD) and the Use of Antipsychotics.
    Calsolaro V; Femminella GD; Rogani S; Esposito S; Franchi R; Okoye C; Rengo G; Monzani F
    Pharmaceuticals (Basel); 2021 Mar; 14(3):. PubMed ID: 33803277
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The management of inappropriate vocalisation in dementia: a hierarchical approach.
    Barton S; Findlay D; Blake RA
    Int J Geriatr Psychiatry; 2005 Dec; 20(12):1180-6. PubMed ID: 16315148
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Atypical antipsychotics for Parkinson's disease psychosis: a systematic review and meta-analysis.
    Zhang H; Wang L; Fan Y; Yang L; Wen X; Liu Y; Liu Z
    Neuropsychiatr Dis Treat; 2019; 15():2137-2149. PubMed ID: 31551655
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Cytochrome P450 (CYP450) Interactions Involving Atypical Antipsychotics are Common in Community-Dwelling Older Adults Treated for Behavioral and Psychological Symptoms of Dementia.
    Matos A; Bain KT; Bankes DL; Furman A; Skalski B; Verzicco J; Turgeon J
    Pharmacy (Basel); 2020 Apr; 8(2):. PubMed ID: 32276526
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Pharmacotherapy in Patients with Alzheimer-type Dementia Presenting with Behavioral and Psychological Symptoms of Dementia: A Retrospective Chart Review of 102 Patients Available for 12-month Follow-up after Initiation of Treatment.
    Fujita M; Ishizuka T
    Juntendo Iji Zasshi; 2023; 69(5):370-377. PubMed ID: 38845733
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analgesics in the management of behavioral and psychological symptoms of dementia: a perspective review.
    Tampi RR; Hassell C; Joshi P; Tampi DJ
    Drugs Context; 2017; 6():212508. PubMed ID: 29209402
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antipsychotic use in dementia: a systematic review of benefits and risks from meta-analyses.
    Tampi RR; Tampi DJ; Balachandran S; Srinivasan S
    Ther Adv Chronic Dis; 2016 Sep; 7(5):229-45. PubMed ID: 27583123
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antipsychotics in the Management of Disruptive Behavior Disorders in Children and Adolescents: An Update and Critical Review.
    Rajkumar RP
    Biomedicines; 2022 Nov; 10(11):. PubMed ID: 36359338
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Efficacy and Safety Considerations With Second-Generation Antipsychotics as Adjunctive Analgesics: A Review of Literature.
    Coronado B; Dunn J; Veronin MA; Reinert JP
    J Pharm Technol; 2021 Aug; 37(4):202-208. PubMed ID: 34752579
    [No Abstract]   [Full Text] [Related]  

  • 40.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.